@article {2290, title = {Malaria severity and human nitric oxide synthase type 2 (NOS2) promoter haplotypes.}, journal = {Human Genetics}, volume = {127}, year = {2010}, month = {2010 Feb}, pages = {163-82}, abstract = {

Nitric oxide (NO) mediates host resistance to severe malaria and other infectious diseases. NO production and mononuclear cell expression of the NO producing enzyme-inducible nitric oxide synthase (NOS2) have been associated with protection from severe falciparum malaria. The purpose of this study was to identify single nucleotide polymorphisms (SNPs) and haplotypes in the NOS2 promoter, to identify associations of these haplotypes with malaria severity and to test the effects of these polymorphisms on promoter activity. We identified 34 SNPs in the proximal 7.3 kb region of the NOS2 promoter and inferred NOS2 promoter haplotypes based on genotyping 24 of these SNPs in a population of Tanzanian children with and without cerebral malaria. We identified 71 haplotypes; 24 of these haplotypes comprised 82\% of the alleles. We determined whether NOS2 promoter haplotypes were associated with malaria severity in two groups of subjects from Dar es Salaam (N = 185 and N = 250) and in an inception cohort of children from Muheza-Tanga, Tanzania (N = 883). We did not find consistent associations of NOS2 promoter haplotypes with malaria severity or malarial anemia, although interpretation of these results was potentially limited by the sample size of each group. Furthermore, cytokine-induced NOS2 promoter activity determined using luciferase reporter constructs containing the proximal 7.3 kb region of the NOS2 promoter and the G-954C or C-1173T SNPs did not differ from NOS2 promoter constructs that lacked these polymorphisms. Taken together, these studies suggest that the relationship between NOS2 promoter polymorphisms and malaria severity is more complex than previously described.

}, keywords = {Alleles, Base Sequence, Cell Line, Child, DNA, Gene Frequency, Genetic, Genetic Heterogeneity, Genotype, Haplotypes, Humans, Infant, Kenya, Linkage Disequilibrium, Malaria, Molecular Sequence Data, Mutation, Nitric Oxide Synthase Type II, Nucleic Acid, Polymorphism, Preschool, Promoter Regions, Sequence Analysis, Sequence Homology, Severity of Illness Index, Single Nucleotide, Tanzania, Tumor}, issn = {1432-1203}, doi = {10.1007/s00439-009-0753-3}, author = {Levesque, Marc C and Hobbs, Maurine R and O{\textquoteright}Loughlin, Charles W and Chancellor, Jennifer A and Chen, Youwei and Tkachuk, Ariana N and Booth, Jennifer and Patch, Kistie B and Allgood, Sallie and Pole, Ann R and Fernandez, Carolyn A and Mwaikambo, Esther D and Mutabingwa, Theonest K and Fried, Michal and Sorensen, Bess and Duffy, Patrick E and Granger, Donald L and Anstey, Nicholas M and Weinberg, J Brice} } @article {2292, title = {Inducible nitric oxide synthase (NOS2) promoter CCTTT repeat polymorphism: relationship to in vivo nitric oxide production/NOS activity in an asymptomatic malaria-endemic population.}, journal = {The American Journal of Tropical Medicine and Hygiene}, volume = {69}, year = {2003}, month = {2003 Dec}, pages = {569-73}, abstract = {

Polymorphisms in the inducible nitric oxide synthase gene (NOS2) promoter have been associated with clinical outcome from malaria. These include a CCTTT repeat (CCTTTn) 2.5 kilobases upstream from the NOS2 transcription start site, and two single nucleotide substitutions: G{\textendash}\>C at position -954 (G-954C), and C{\textendash}\>T at position -1173 (C-1173T). Although hypothesized to influence NO production in vivo, the functional relevance of (CCTTT)n and G-954C is uncertain because disease association studies have yielded inconsistent results. This study found no association between CCTTT repeat number and levels of plasma NO metabolites or peripheral blood mononuclear cell NOS activity in a cohort of asymptomatic malaria-exposed coastal Papua New Guineans 1-60 years old. This suggests that (CCTTT)n does not independently influence NOS2 transcription in vivo. Neither the G-954C nor the C-1173T polymorphisms were identified in this population, indicating the variability and complexity of selection for NOS2 promoter polymorphisms in different malaria-endemic populations.

}, keywords = {Endemic Diseases, Female, Genetic, Genetic Predisposition to Disease, Humans, Malaria, Male, Nitric Oxide, Nitric Oxide Synthase, Nitric Oxide Synthase Type II, Nucleic Acid, Oceanic Ancestry Group, Papua New Guinea, Polymorphism, Promoter Regions, Repetitive Sequences}, issn = {0002-9637}, author = {Boutlis, Craig S and Hobbs, Maurine R and Marsh, Robyn L and Misukonis, Mary A and Tkachuk, Ariana N and Lagog, Moses and Booth, Jennifer and Granger, Donald L and Bockarie, Moses J and Mgone, Charles S and Levesque, Marc C and Weinberg, J Brice and Anstey, Nicholas M} } @article {2295, title = {A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children.}, journal = {Lancet}, volume = {360}, year = {2002}, month = {2002 Nov 9}, pages = {1468-75}, abstract = {

Nitric oxide (NO) is a mediator of immunity to malaria, and genetic polymorphisms in the promoter of the inducible NO synthase gene (NOS2) could modulate production of NO. We postulated that NOS2 promoter polymorphisms would affect resistance to severe malaria.

}, keywords = {Anemia, Cerebral, Child, DNA, Falciparum, Female, Genetic, Humans, Immunity, Infant, Innate, Kenya, Malaria, Male, Nitric Oxide, Nitric Oxide Synthase, Nitric Oxide Synthase Type II, Parasitemia, Polymorphism, Preschool, Sequence Analysis, Single-Stranded Conformational, Tanzania}, issn = {0140-6736}, doi = {10.1016/S0140-6736(02)11474-7}, author = {Hobbs, Maurine R and Udhayakumar, Venkatachalam and Levesque, Marc C and Booth, Jennifer and Roberts, Jacquelin M and Tkachuk, Ariana N and Pole, Ann and Coon, Hilary and Kariuki, Simon and Nahlen, Bernard L and Mwaikambo, Esther D and Lal, Altaf L and Granger, Donald L and Anstey, Nicholas M and Weinberg, J Brice} }